← Clinical Evidence

SRC-0acf3ac4a484 Lima LO 2016

Evidence source and scope

Work and power reduced in L-dopa naïve patients in the early-stages of Parkinson’s disease.

This note indexes a cited or audit-added source. It may be an original study, review, guideline, form or methods reference. Treat the specific design and the evidence below as authoritative; a source note is not automatically a primary study.

DOI: 10.1590/0004-282x20160014

Bibliographic record from the original reports

Access labels embedded in these original reference strings are historical. Current access and exact checked components are stated separately below.

Lima LO, Cardoso F, Teixeira-Salmela LF, Rodrigues-de-Paula F. Work and power reduced in L-dopa naïve patients in the early-stages of Parkinson’s disease. Arquivos de Neuro-Psiquiatria. 2016;74(4):287–292. DOI 10.1590/0004-282x20160014

Conditions: COND-PD Parkinson’s disease

Scoped audit evidence

These are source- and component-level audit summaries as of 3 October 2026. Access and comparison scope can differ by report; none certifies every result or the underlying raw data.

Parkinson’s disease — strength

STR-17-01

Limitations: Only current scoped checks; archived captures not authenticated against live originals.

Parkinson’s disease strength

Parkinson’s disease strength component — Power study sample and levodopa-naive status

The abstract confirms 10 levodopa-naive PD participants at HY I–II, 10 controls and isokinetic trunk/lower-limb power. It does not establish absence of other medication or the review's precise ratios.

Source locator: Primary Pub Med/Europe PMC abstract

Limitations: Review power figure now checked in STR-16-04. Exact medication regimen in Lima original Methods remains unavailable; report explicitly leaves it unresolved. AI-assisted source comparison; no raw-data verification.

Reports citing this source

Update record

Updating the wiki · Evidence and status guide